- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07914452
Personalized Routine and Habit Integration to Support Medication Management (PRISM)
A Randomized Controlled Trial of the Personalized Routine and Habit Integration to Support Medication Management Intervention (PRISM)
The objective of this study is to test a multidisciplinary care team behavioral intervention to enhance medication adherence among older adults with multiple chronic conditions (MCC). The Personalized Routine and Habit Integration to Support Medication Management (PRISM) intervention is a novel, scalable intervention delivered by pharmacists and occupational therapists (OTs) that aims to improve medication adherence by reducing regimen complexity and solidifying medication habits within daily routines. The goal of this randomized control trial is to evaluate the effectiveness and implementation of PRISM compared with enhanced usual care.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Julie Lauffenburger, PharmD, PhD
- Telefonnummer: 857-282-1962
- E-mail: jlauffenburger@bwh.harvard.edu
Studiesteder
-
-
Massachusetts
-
Somerville, Massachusetts, Forenede Stater, 021250
- Mass General Brigham
-
Kontakt:
- Julie Lauffenburger, PharmD, PhD
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- appointment in the past 18 months in the Galter-18 primary care practice
- ≥2 cardiovascular and/or metabolic chronic conditions documented in the EHR,
- ≥5 daily medications
- poor medication adherence ≥1 cardiovascular and/or metabolic medication using validated EHR-data algorithms
- English-speaking
- ≥65 years old
Exclusion Criteria:
- severe mental illness
- dementia
- dependent on others for medication management
- have received a pharmacist-led comprehensive medication review in the last 6 months
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Sundhedstjenesteforskning
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: PRISM Arm
The PRISM arm will receive three sessions: 1) comprehensive medication management session with a clinical pharmacist, 2) an in-home visit with an occupational therapist (OT), and then 3) follow up phone call with OT. |
The PRISM arm will receive three sessions: 1) comprehensive medication management session with a clinical pharmacist, 2) an in-home visit with an occupational therapist (OT), and then 3) follow up phone call with OT. |
|
Eksperimentel: Enhanced usual care (EUC) arm
The EUC arm will receive a comprehensive medication management session with a clinical pharmacist. |
The EUC arm will receive a comprehensive medication management session with a clinical pharmacist. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
PDC (Continuous) - Cardiometabolic
Tidsramme: Through 6-months post-baseline
|
Medication adherence to cardio-metabolic pill-form daily medications including the following classes: ACE inhibitor, Angiotensin Receptor Blockers (ARBs), Beta-Blockers, Calcium Channel Blockers, Diuretics, Lipid-lowering, Metformin |
Through 6-months post-baseline
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
PDC (Continuous) - All
Tidsramme: Through 6-months post-baseline
|
Medication adherence to all daily prescription pill-form medications |
Through 6-months post-baseline
|
|
PDC (Continuous) - Study-entering
Tidsramme: Through 6-months post-baseline
|
Medication adherence to study-entering medication i.e. the medciation that was identified during the eligibility screening process as having poor medication adherence. |
Through 6-months post-baseline
|
|
Medication Adherence Report Scale 10-item (MARS-10)
Tidsramme: Through 3-months post-baseline
|
Self reported; medication ahderence to all prescriptoin daily medications |
Through 3-months post-baseline
|
|
Regimen Knowledge (continuous)
Tidsramme: Through 3-months post-baseline
|
Participant knowledge of prescribed medications, including their purpose, dosage, and administration instructions using Medication Purpose & Dosage Identification Score (MPDS). |
Through 3-months post-baseline
|
|
Regimen Complexity (continuous)
Tidsramme: Through 3-months post-baseline
|
Complexity of the participant's prescribed medication regime using Medication Regimen Complexity Index (MRCI). |
Through 3-months post-baseline
|
|
Daily Routine (continuous)
Tidsramme: Through 3-months post-baseline
|
Daily activity patterns and routines, including the timing of activities throughout the day using a time diary. |
Through 3-months post-baseline
|
|
Medication Habits (continuous)
Tidsramme: Through 3-months post-baseline
|
The extent to which medication-taking is performed automatically as a habitual behavior using Self-Report Behavioral Automaticity Index (SRBAI). |
Through 3-months post-baseline
|
|
Problem Solving Skills (continuous)
Tidsramme: Through 3-months post-baseline
|
Participant ability to identify, address, and learn from problems affecting medication-taking and health management using Health Problem-Solving Scale (HPSS). |
Through 3-months post-baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2026P001972
- 5P30AG064199-08 (U.S. NIH-bevilling/kontrakt)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .